About: NeOnc Technologies Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on developing treatments for intracranial malignancies. Its lead product candidates include NEO100, a purified form of preillyl acid that is in Phase IIa clinical trial; and NEO212, a covalently conjugated molecule combining chemotherapeutic drug temozolomide with perillyl alcohol that is in Phase I/II clinical trials for its oral administration for the treatment of primary brain cancers, such as meningioma, high grade gliomas, glioblastoma, and secondary brain cancers. The company was formerly known as NAS-ONC, Inc. and changed its name to NeOnc Technologies Holdings, Inc. in 2009. The company was incorporated in 2005 and is headquartered in Calabasas, California.
Sector: Healthcare
Industry: Biotechnology
Latest price: $2.81 (+2.18%)
NTHI NASDAQ NeOnc Technologies Holdings, Inc. Common Stock
NeOnc Technologies Holdings, Inc. Common Stock share price
NTHI price activity
Last Price
$2.810
Change (24hr)
0.06 USD (2.18%)
Volume
25.87K
Volume (4w avg)
-
Open
$2.80
Day Range
$2.80 - $2.81
Previous Close
$2.75
Last Trade
16 Oct, 2:20 pm GMT+0
Delayed
16 Oct, 2:20 pm GMT+0
NTHI price performance
Delayed
16 Oct, 2:20 pm GMT+0
NTHI Market Signals